Literature DB >> 1950477

Nigral degeneration in acquired immune deficiency syndrome (AIDS).

M G Reyes1, F Faraldi, C S Senseng, C Flowers, R Fariello.   

Abstract

Using stereological techniques we have estimated the volume density of melanin and counted the number of pigmented and non-pigmented neuronal cell bodies in the pars compacta of the substantia nigra of 12 autopsied patients with acquired immune deficiency syndrome (AIDS) who did not have inflammation or necrosis of the midbrain or clinical parkinsonism. The total number of neuronal cell bodies was 25% lower in AIDS (P less than 0.01) than in 12 age-matched controls, although the volume density of neuronal melanin did not differ from that of controls because the percentage of pigmented cell bodies was higher (P less than 0.01) and the cell bodies were more fully packed with melanin in AIDS. Also, the expected increase with age of the volume density of neuronal melanin (P less than 0.02) and the percentage of pigmented neurons (P less than 0.01) occurred in the controls but not in AIDS patients. Importantly, our histopathological examination showed unequivocal nigral degeneration with neuronal loss, small neuronal cell bodies packed with melanin, reactive astrocytosis and extra-cellular melanin in the AIDS patients but not in controls. Our study shows that a subclinical nigral degeneration is common in AIDS and could possibly explain the heightened susceptibility of some patients to drug-induced parkinsonism.

Entities:  

Mesh:

Year:  1991        PMID: 1950477     DOI: 10.1007/bf00310921

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

Review 1.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

2.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

3.  Severe parkinsonism in two AIDS patients taking prochlorperazine.

Authors:  H Edelstein; R T Knight
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

4.  Wernicke's encephalopathy in AIDS patient treated with zidovudine.

Authors:  D G Davtyan; H V Vinters
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

5.  Azidothymidine neurotoxicity.

Authors:  D N Hagler; P T Frame
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

6.  Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.

Authors:  C K Petito; E S Cho; W Lemann; B A Navia; R W Price
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

7.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.

Authors:  C A Wiley; R D Schrier; J A Nelson; P W Lampert; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Movement disorders and AIDS.

Authors:  A Nath; J Jankovic; L C Pettigrew
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

9.  Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS).

Authors:  H Mizusawa; A Hirano; J F Llena; M Shintaku
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.

Authors:  P A Ballard; J W Tetrud; J W Langston
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

View more
  53 in total

1.  Acceleration of HIV dementia with methamphetamine and cocaine.

Authors:  A Nath; W F Maragos; M J Avison; F A Schmitt; J R Berger
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

Review 4.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

5.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

6.  Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.

Authors:  Italo Mocchetti; Alessia Bachis; Rachel L Nosheny; Gianluigi Tanda
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 7.  Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.

Authors:  Italo Mocchetti; Alessia Bachis; Lee A Campbell; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-06       Impact factor: 4.147

8.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

9.  Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia.

Authors:  I P Everall; J D Glass; J McArthur; E Spargo; P Lantos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 10.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.